By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Invion Limited 

2/120 Bluestone Circuit

Seventeen Mile Rocks    QLD 4073  Australia
Phone: 61-7-3295-0500 Fax: 61-7-3295-0599


SEARCH JOBS


Industry
Pharmaceutical






Company News
Invion Limited Completes Dosing In Key Phase II Clinical Trial Of Oral INV102 (Nadolol) In Smoking Cessation 6/29/2015 9:55:13 AM
Invion Limited Release: INV102 (Oral Nadolol) Data Presented To American Thoracic Society Meeting In Denver, Colorado 5/19/2015 9:38:02 AM
FDA Accepts Invion Limited Proposal To Progress Development Of Inhaled Nadolol To Treat Chronic Respiratory Diseases 3/23/2015 9:49:41 AM
Invion Limited Shows Off Positive Phase 2 Data for Smokers Trying to Quit 1/19/2015 7:25:58 AM
Invion Limited Announces $17.4 Million Investment 11/10/2014 8:33:07 AM
Invion Limited Provides Update To U.S. FDA On Phase II Study Of Nadolol In Mild Asthma (NIMA) 9/23/2014 9:33:42 AM
Update On Invion Limited’s Phase II Study Of INV103 (Ala-Cpn10) In Lupus Patients 9/8/2014 1:51:54 PM
Invion Limited Announces Completion Of $5 Million Placement And Intention To Conduct $2 Million Rights Issue 2/21/2014 8:19:47 AM
Invion Limited To Collaborate With 3M Drug Delivery Systems On Inhaled Versions Of Inv102 (Nadolol) And Inv104 (Zafirlukast) 2/19/2014 9:08:46 AM
Invion Limited Announces Commencement of Phase 2 Chronic Bronchitis Clinical Trial 7/22/2013 8:30:43 AM
12
//-->